Gene ther­apy halts fatal brain disease

Gulf News - - FRONT PAGE -

Devel­op­ment leads the way for more pro­gres­sive de­vel­op­ments in treat­ing adrenoleu kodys­tro­phy |

Sci­en­tists have devel­oped a new gene test for breast can­cer pa­tients, which could in­form women how likely they are to de­velop breast can­cer, and can lead to fewer women be­ing di­ag­nosed with the deadly disease.

The test known as Sin­gle Nu­cleotide Poly­mor­phism (SNP) could help re­duce the num­ber of women hav­ing surgery to re­move their breasts to nar­row down their risk.

The test will ini­tially be avail­able for pa­tients hav­ing BRCA1 and 2 gene mu­ta­tions, with a fam­ily his­tory of breast can­cer.

“This is a mas­sive game changer for breast can­cer where we now have tests which can give ac­cu­rate risk in the whole pop­u­la­tion, those with a fam­ily his­tory and those with BRCA mu­ta­tions,” pro­fes­sor Gareth Evans, from the Manch­ester Univer­sity was quoted as say­ing to the BBC. The SNP test, con­ducted on blood or saliva, looks at 18 ge­netic vari­ants known to af­fect the chances of get­ting breast can­cer.

Com­bin­ing the in­for­ma­tion on breast den­sity, the age a woman has chil­dren or reaches pu­berty, the test gives women a per­cent­age change of de­vel­op­ing breast can­cer within the next 10 years, and through­out their life­time, the re­searchers said.

Newspapers in English

Newspapers from UAE

© PressReader. All rights reserved.